Back to News
Market Impact: 0.45

Morgan Stanley (MS) Q3 2026 Earnings Call Transcript

Source: The Motley Fool

Corporate EarningsCompany FundamentalsBanking & LiquidityCapital Returns (Dividends / Buybacks)Artificial IntelligenceCorporate Guidance & OutlookInterest Rates & Yields

Morgan Stanley reported Q3 revenue of $20.3 billion, up from $18.2 billion a year earlier, EPS of $3.03 versus $2.80, and ROTCE of 22.6%, its fifth consecutive quarter above 20%. Wealth Management posted record revenue of $9.1 billion and net new assets of $232.4 billion, while Institutional Securities revenue rose 18% year over year to $10.0 billion; the firm repurchased $1.5 billion of stock and ended with a 14.9% CET1 ratio. Management expects a modest Q4 increase in net interest income and expects NII to expand next year, but cited higher rates, energy prices and geopolitical uncertainty as risks; CEO Ted Pick said the firm is “double overweight” on AI infrastructure.

Analysis

The key distinction is between durable franchise growth and a particularly favorable market quarter. Wealth’s acquisition funnel can compound fee revenue, but headline asset gathering is not yet equivalent to recurring advisory economics: IPO-related assets can leave, remain self-directed, or be spent. The conversion rate into fee-based relationships—and retention after lockups expire—matters more than another record in gross flows. Watch fee-based flows and Wealth margin together over the next 1–3 quarters.

Near term, equities and advisory earnings remain exposed to activity and risk appetite; the sequential slowdown described by management makes extrapolating the strong equities result hazardous. Conversely, the deposit build is a timing trade-off: a less favorable mix can weigh on NII now, while funding benefits are expected to emerge later. That benefit is conditional on rates, deposit pricing, and loan demand, not an automatic consequence of deposit growth.

The AI angle is asymmetric. Morgan Stanley may earn advisory and financing fees without owning the infrastructure assets, but its willingness to deepen exposure also raises the cost of misjudging project economics, leverage, or financing windows. Higher real rates or an energy/power bottleneck could defer projects, weaken deal activity, and pressure borrowers simultaneously. Over 6–18 months, the strongest confirmation would be fee-based conversion and operating leverage holding up as markets normalize; a reversal in IPO-related flows or credit deterioration would challenge the durability case. The balance-sheet buffer is useful optionality, not immunity to higher RWAs or risk losses.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.55

Ticker Sentiment

MS0.75

Key Decisions for Investors

  • Avoid chasing the earnings-day strength. Consider a staged long in MS on a market-led pullback, with the thesis anchored to fee-based flow conversion rather than peak trading revenue. Reassess if fee-based flows weaken materially for two consecutive quarters or Wealth pretax margin contracts despite continued asset gathering.
  • Treat the deposit/NII story as a watch item, not a near-term earnings catalyst. Verify deposit mix and pricing, loan growth, and reported NII before underwriting the expected 2027 funding benefit; a failure of NII to improve alongside loan growth would falsify it.
  • Keep position sizing mindful of cyclical downside: reduce exposure if institutional equities activity and advisory pipelines soften together, or if credit provisions rise beyond portfolio growth. Higher real rates and worsening energy/geopolitical shocks are key near-term catalysts for that downside.
  • Monitor AI-related underwriting and financing exposure rather than treating management’s strategic emphasis as proof of monetization. Evidence of delayed financings, weaker borrower credit quality, or rising risk-weighted assets without commensurate fee growth would argue against adding to MS.

More News

From AllMind Research

Browse all research